FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3148746985> ?p ?o ?g. }

• W3148746985 abstract "Abstract Background Lifestyle intervention, i.e. diet and physical activity, forms the basis for care of type 2 diabetes (T2D). The current physical activity recommendation for T2D is aerobic training for 150 min/week of moderate to vigorous intensity, supplemented with resistance training 2–3 days/week, with no more than two consecutive days without physical activity. The rationale for the recommendations is based on studies showing a reduction in glycated haemoglobin (HbA1c). This reduction is supposed to be caused by increased insulin sensitivity in muscle and adipose tissue, whereas knowledge about effects on abnormalities in the liver and pancreas are scarce, with the majority of evidence stemming from in vitro and animal studies. The aim of this study is to investigate the role of the volume of exercise training as an adjunct to dietary therapy in order to improve the pancreatic β-cell function in T2D patients less than 7 years from diagnosis. The objective of this protocol for the DOSE-EX trial is to describe the scientific rationale in detail and to provide explicit information about study procedures and planned analyses. Methods/design In a parallel-group, 4-arm assessor-blinded randomised clinical trial, 80 patients with T2D will be randomly allocated (1:1:1:1, stratified by sex) to 16 weeks in either of the following groups: (1) no intervention (CON), (2) dietary intervention (DCON), (3) dietary intervention and supervised moderate volume exercise (MED), or (4) dietary intervention and supervised high volume exercise (HED). Enrolment was initiated December 15th, 2018, and will continue until N = 80 or December 1st, 2021. Primary outcome is pancreatic beta-cell function assessed as change in late-phase disposition index (DI) from baseline to follow-up assessed by hyperglycaemic clamp. Secondary outcomes include measures of cardiometabolic risk factors and the effect on subsequent complications related to T2D. The study was approved by The Scientific Ethical Committee at the Capital Region of Denmark (H-18038298). Trial registration: The Effects of Different Doses of Exercise on Pancreatic β-cell Function in Patients With Newly Diagnosed Type 2 Diabetes (DOSE-EX), NCT03769883, registered 10 December 2018 https://clinicaltrials.gov/ct2/show/NCT03769883 ). Any modification to the protocol, study design, and changes in written participant information will be approved by The Scientific Ethical Committee at the Capital Region of Denmark before effectuation. Discussion The data from this study will add knowledge to which volume of exercise training in combination with a dietary intervention is needed to improve β-cell function in T2D. Secondarily, our results will elucidate mechanisms of physical activity mitigating the development of micro- and macrovascular complications correlated with T2D." @default.
• W3148746985 created "2021-04-13" @default.
• W3148746985 creator A5000200925 @default.
• W3148746985 creator A5001134228 @default.
• W3148746985 creator A5014406184 @default.
• W3148746985 creator A5014703839 @default.
• W3148746985 creator A5017963639 @default.
• W3148746985 creator A5019980330 @default.
• W3148746985 creator A5033826448 @default.
• W3148746985 creator A5036393751 @default.
• W3148746985 creator A5047661122 @default.
• W3148746985 creator A5051857476 @default.
• W3148746985 creator A5054382982 @default.
• W3148746985 creator A5059817069 @default.
• W3148746985 creator A5060667007 @default.
• W3148746985 creator A5060815860 @default.
• W3148746985 creator A5065526075 @default.
• W3148746985 creator A5072411696 @default.
• W3148746985 creator A5076561520 @default.
• W3148746985 creator A5079737309 @default.
• W3148746985 creator A5085414225 @default.
• W3148746985 creator A5089630543 @default.
• W3148746985 date "2021-04-01" @default.
• W3148746985 modified "2023-09-30" @default.
• W3148746985 title "The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial" @default.
• W3148746985 cites W1258310052 @default.
• W3148746985 cites W1526927233 @default.
• W3148746985 cites W172609984 @default.
• W3148746985 cites W1792680009 @default.
• W3148746985 cites W1967265218 @default.
• W3148746985 cites W1969171226 @default.
• W3148746985 cites W1969583122 @default.
• W3148746985 cites W1974422758 @default.
• W3148746985 cites W1978890783 @default.
• W3148746985 cites W1991060376 @default.
• W3148746985 cites W1993299437 @default.
• W3148746985 cites W1995980256 @default.
• W3148746985 cites W1998109668 @default.
• W3148746985 cites W1998207473 @default.
• W3148746985 cites W2008564665 @default.
• W3148746985 cites W2012385028 @default.
• W3148746985 cites W2013629598 @default.
• W3148746985 cites W2020599247 @default.
• W3148746985 cites W2025870581 @default.
• W3148746985 cites W2027764283 @default.
• W3148746985 cites W2031314683 @default.
• W3148746985 cites W2039961296 @default.
• W3148746985 cites W2047243213 @default.
• W3148746985 cites W2051587831 @default.
• W3148746985 cites W2051999166 @default.
• W3148746985 cites W2052619923 @default.
• W3148746985 cites W2057242413 @default.
• W3148746985 cites W2058221507 @default.
• W3148746985 cites W2061410297 @default.
• W3148746985 cites W2061450364 @default.
• W3148746985 cites W2062684905 @default.
• W3148746985 cites W2065590498 @default.
• W3148746985 cites W2081401007 @default.
• W3148746985 cites W2082622955 @default.
• W3148746985 cites W2091101983 @default.
• W3148746985 cites W2099244083 @default.
• W3148746985 cites W2099929025 @default.
• W3148746985 cites W2100378647 @default.
• W3148746985 cites W2100862440 @default.
• W3148746985 cites W2103680156 @default.
• W3148746985 cites W2104498985 @default.
• W3148746985 cites W2104983431 @default.
• W3148746985 cites W2108453323 @default.
• W3148746985 cites W2109728760 @default.
• W3148746985 cites W2111645882 @default.
• W3148746985 cites W2111648449 @default.
• W3148746985 cites W2115702661 @default.
• W3148746985 cites W2117133172 @default.
• W3148746985 cites W2124081028 @default.
• W3148746985 cites W2130695219 @default.
• W3148746985 cites W2134285290 @default.
• W3148746985 cites W2136330374 @default.
• W3148746985 cites W2136896338 @default.
• W3148746985 cites W2137334382 @default.
• W3148746985 cites W2144707471 @default.
• W3148746985 cites W2150367899 @default.
• W3148746985 cites W2155231441 @default.
• W3148746985 cites W2156497704 @default.
• W3148746985 cites W2158666727 @default.
• W3148746985 cites W2160901128 @default.
• W3148746985 cites W2183649177 @default.
• W3148746985 cites W2190409916 @default.
• W3148746985 cites W2267618570 @default.
• W3148746985 cites W2277297397 @default.
• W3148746985 cites W2282195952 @default.
• W3148746985 cites W2337454357 @default.
• W3148746985 cites W2401395734 @default.
• W3148746985 cites W2412299019 @default.
• W3148746985 cites W2470838351 @default.
• W3148746985 cites W2517945165 @default.
• W3148746985 cites W2531807162 @default.
• W3148746985 cites W2536270858 @default.
• W3148746985 cites W2560249221 @default.
• W3148746985 cites W2560794920 @default.
• W3148746985 cites W2582793111 @default.

• next